Table 1. . Overview of current methods for measuring anandamide and 2-arachidonoyl glycerol.
| Species | Biological sample | Purpose of study | Sample preparation and analysis | Analytical figures for AEA and 2-AG respectively | Ref. |
|---|---|---|---|---|---|
| Human | Plasma | Quantitation of ECs, prostanoids and steroids | Solid-phase extraction; LC–MS/MS | LOQ 0.1 ng/ml; 3.2 ng/ml | [16] |
| Rat | Tissues | Quantitation of ECs, ceramides and oxysterols | Solid-phase extraction; LC–MS | LOQ 1.7 pmol; 2.5 pmol (on column) | [17] |
| Black bear | Serum | Quantitation of 5 ECs in serum | Liquid–liquid extraction; microflow LC–MS/MS | LOQ 1.7 pg/ml; 13.4 pg/l | [18] |
| Human | Plasma | Quantitation of ECs | Liquid–liquid extraction; LC–MS/MS | LOQ 0.5 nM (AEA only) | [19] |
| Human | Plasma | Quantitation of AEA and ethanol amides | Liquid–liquid extraction; GC–MS/MS | LOQ 0.25 nM (AEA only) | [21] |
| Human | Serum | Quantitation of 14 ECs in serum | Solid-phase extraction; LC–MS/MS | LOQ at pg/ml level for all 14 ECs | [23] |
| Rat | Hypothalamus | Regulation of EC release by CB1 receptors | MD, microSPE; LC–MS/MS | LOQ 30 amol; 300 amol (on column) | [24] |
2-AG: 2-arachidonoyl glycerol; AEA: Anandamide; CB: Cannabinoid; EC: Endocannabinoid; LOQ: Limit of quantitation; MD: Microdialysis; SPE: Solid phase extraction.